Home » Novartis Seeks to Buy Rest of Alcon for $39 Billion
Novartis Seeks to Buy Rest of Alcon for $39 Billion
Swiss drugmaker Novartis aims to buy the rest of the world’s biggest eye care firm Alcon for $39.3 billion, including Nestle’s
majority stake, to help it diversify away from prescription drugs.
Oregon Herald
Oregon Herald
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May